0,823  0,003  5 Hydroxytryptamine release stimulant
0,640  0,009  Immunosuppressant
0,627  0,010  Spasmolytic
0,612  0,025  Analgesic
0,553  0,005  Sigma receptor agonist
0,548  0,004  Pneumotoxic
0,559  0,022  Respiratory analeptic
0,547  0,011  Cardiodepressant
0,530  0,010  Dependence treatment
0,510  0,004  Analgesic, opioid
0,502  0,025  CYP2D6 substrate
0,511  0,055  Caspase 9 stimulant
0,478  0,022  UGT1A9 substrate
0,452  0,003  Opioid mu receptor agonist
0,441  0,004  Opioid agonist
0,439  0,004  Opioid kappa receptor antagonist
0,450  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,460  0,033  CYP2C19 substrate
0,463  0,038  Aldehyde oxidase inhibitor
0,416  0,006  Toxic, respiratory center
0,414  0,004  Opioid antagonist
0,454  0,050  CYP3A4 substrate
0,432  0,031  Analeptic
0,397  0,004  Opioid mu receptor antagonist
0,396  0,009  Tyrosine 3 hydroxylase inhibitor
0,386  0,004  Dopamine D1 antagonist
0,393  0,012  UGT1A3 substrate
0,436  0,056  Transcription factor NF kappa B inhibitor
0,375  0,014  UGT2B7 substrate
0,416  0,058  CYP2C9 substrate
0,365  0,023  Sedative
0,360  0,021  UGT1A1 substrate
0,328  0,008  UGT2B9 substrate
0,327  0,008  Antitussive
0,323  0,005  Constipation treatment
0,340  0,024  Muscle relaxant
0,314  0,005  Opioid delta receptor antagonist
0,302  0,013  Antidiarrheal
0,310  0,021  Antialcoholic
0,339  0,054  CYP1A2 substrate
0,325  0,045  Tumour necrosis factor alpha release inhibitor
0,393  0,117  Apoptosis agonist
0,279  0,005  Dopamine agonist
0,323  0,052  UGT2B4 substrate
0,349  0,080  Antineoplastic (lung cancer)
0,338  0,070  Prostate cancer treatment
0,328  0,066  Calcium channel activator
0,265  0,004  Dopamine D2 agonist
0,327  0,067  AR expression inhibitor
0,293  0,035  5 Hydroxytryptamine 1E antagonist
0,285  0,037  Anesthetic general
0,252  0,004  Prolactin inhibitor
0,266  0,020  Interleukin 6 antagonist
0,297  0,056  Sensitization
0,331  0,092  Ulceration
0,242  0,004  Dopamine D5 antagonist
0,235  0,004  Opioid kappa receptor agonist
0,239  0,017  UGT2B10 substrate
0,326  0,106  CYP2C19 inhibitor
0,244  0,024  LDLR expression enhancer
0,226  0,008  Sigma receptor antagonist
0,270  0,052  Psychostimulant
0,241  0,026  Antidote
0,261  0,050  Antiparkinsonian, rigidity relieving
0,301  0,092  Angiogenesis inhibitor
0,229  0,023  Cocaine dependence treatment
0,276  0,072  Antioxidant
0,235  0,032  Antiparkinsonian, tremor relieving
0,272  0,070  Teratogen
0,279  0,078  FMO3 substrate
0,250  0,049  UDP-glucuronosyltransferase substrate
0,234  0,033  Cholinergic
0,264  0,066  Cardiovascular analeptic
0,280  0,083  CYP2D6 inhibitor
0,264  0,068  5 Hydroxytryptamine uptake stimulant
0,196  0,004  Narcotic antagonist
0,223  0,031  Tubulin antagonist
0,220  0,029  Genotoxic
0,256  0,066  Free radical scavenger
0,268  0,087  Cardioprotectant
0,202  0,023  Alpha 2b adrenoreceptor antagonist
0,215  0,036  Skeletal muscle relaxant
0,192  0,016  Antineoplastic alkaloid
0,195  0,019  Dopamine antagonist
0,198  0,027  5 Hydroxytryptamine 2B antagonist
0,186  0,018  Dopamine D2 antagonist
0,299  0,131  TNF expression inhibitor
0,215  0,052  UGT1A4 substrate
0,183  0,019  UGT2B1 substrate
0,182  0,022  Alpha 2c adrenoreceptor antagonist
0,220  0,061  Nitric oxide antagonist
0,300  0,141  Antiparkinsonian
0,188  0,029  Alpha adrenoreceptor antagonist
0,196  0,040  Uterine stimulant
0,192  0,035  Acetylcholinesterase inhibitor
0,277  0,123  Cognition disorders treatment
0,227  0,074  UGT1A6 substrate
0,271  0,117  Antileukemic
0,209  0,058  P-glycoprotein inhibitor
0,202  0,053  VEGF expression inhibitor
0,176  0,029  Antiadrenergic
0,227  0,080  Embryotoxic
0,164  0,020  Alpha 2a adrenoreceptor antagonist
0,273  0,132  Antineoplastic (breast cancer)
0,225  0,086  Vasodilator
0,187  0,048  UGT2B15 substrate
0,168  0,030  Adrenaline antagonist
0,223  0,088  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,250  0,117  Antineoplastic (osteosarcoma)
0,152  0,020  Toll-Like receptor 4 antagonist
0,206  0,075  DNA methylase inhibitor
0,127  0,003  Prolactin release inhibitor
0,210  0,087  Cyclic AMP phosphodiesterase inhibitor
0,240  0,121  Caspase 3 stimulant
0,163  0,046  Cholinergic antagonist
0,159  0,046  Acetylcholine antagonist
0,260  0,148  Histamine release inhibitor
0,140  0,030  Alpha 2 adrenoreceptor antagonist
0,195  0,087  Antimitotic
0,242  0,134  Vasodilator, peripheral
0,139  0,032  Alpha 1 adrenoreceptor antagonist
0,108  0,005  Opioid delta receptor agonist
0,201  0,100  Antineoplastic (cervical cancer)
0,212  0,114  Antipsychotic
0,118  0,022  5 Hydroxytryptamine 7 antagonist
0,177  0,082  Hepatoprotectant
0,221  0,127  NOS3 expression inhibitor
0,117  0,025  Tocolytic
0,134  0,042  Expectorant
0,253  0,162  15-Lipoxygenase inhibitor
0,154  0,063  Antineoplastic (squamous cell carcinoma)
0,181  0,091  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,156  0,069  Acetylcholine M1 receptor antagonist
0,121  0,034  UGT2B11 substrate
0,215  0,130  Antidepressant
0,147  0,063  Anesthetic
0,126  0,045  Estrogen antagonist
0,108  0,028  Antiprotozoal activity enhancer
0,094  0,017  Uterine relaxant
0,199  0,123  Radioprotector
0,200  0,126  Antineoplastic (sarcoma)
0,191  0,120  Antihypotensive
0,104  0,035  Alpha 1a adrenoreceptor antagonist
0,112  0,043  Estrogen receptor beta antagonist
0,135  0,067  Toll-Like receptor antagonist
0,087  0,020  Postmenopausal disorders treatment
0,126  0,061  Acetylcholine muscarinic antagonist
0,119  0,055  Chelator
0,101  0,039  Acetylcholine nicotinic antagonist
0,142  0,080  Antimutagenic
0,197  0,135  Antineoplastic (colorectal cancer)
0,115  0,054  Electron transport complex I inhibitor
0,124  0,064  Anesthetic local
0,064  0,004  Dopamine D1 agonist
0,189  0,130  Antineoplastic (colon cancer)
0,178  0,119  NOS2 expression inhibitor
0,085  0,027  Beta tubulin antagonist
0,192  0,135  Antineoplastic (pancreatic cancer)
0,117  0,060  5 Hydroxytryptamine 2 antagonist
0,155  0,098  Lipocortins synthesis antagonist
0,195  0,138  Flavin-containing monooxygenase substrate
0,100  0,045  Restless leg syndrome treatment
0,115  0,062  Cystathionine beta-synthase inhibitor
0,090  0,037  5 Hydroxytryptamine 1F antagonist
0,186  0,134  Superoxide dismutase inhibitor
0,125  0,073  Antineoplastic (uterine cancer)
0,126  0,077  Skin whitener
0,131  0,083  Lipid peroxidase inhibitor
0,158  0,113  Abortion inducer
0,214  0,170  Sodium/bile acid cotransporter inhibitor
0,207  0,163  CTGF expression inhibitor
0,147  0,108  DNA methyltransferase I inhibitor
0,125  0,088  Protein kinase stimulant
0,129  0,095  Antiviral (Influenza A)
0,168  0,135  Cytostatic
0,100  0,067  Nav1.1 sodium channel blocker
0,188  0,156  Antihypoxic
0,119  0,088  Antihemorrhagic
0,073  0,042  Neuronal nicotinic receptor antagonist
0,061  0,030  5 Hydroxytryptamine 7 agonist
0,042  0,012  Sigma 2 receptor antagonist
0,109  0,079  Alkylator
0,135  0,110  Antipruritic, non-allergic
0,053  0,028  Nicotinic receptor alpha4 subunit antagonist
0,167  0,143  Antineoplastic (liver cancer)
0,171  0,149  Antineoplastic (ovarian cancer)
0,026  0,005  NMDA receptor phencyclidine site antagonist
0,063  0,042  Dopamine D3 antagonist
0,112  0,091  Antismoking
0,188  0,168  Mood disorders treatment
0,152  0,135  Neurotrophic factor enhancer
0,104  0,088  Antiseptic
0,103  0,088  M18 aspartyl aminopeptidase inhibitor
0,133  0,117  Cytotoxic
0,138  0,123  Aldehyde oxidase substrate
0,070  0,057  CDC25A inhibitor
0,097  0,084  SULT1A1 substrate
0,049  0,038  Factor III inhibitor
0,064  0,057  Alpha 1b adrenoreceptor antagonist
0,101  0,095  Interleukin 8 antagonist
0,193  0,188  Vasodilator, coronary
0,048  0,044  Alpha tubulin antagonist
0,037  0,033  Dopamine D5 agonist
0,103  0,100  Toll-Like receptor 2 antagonist
0,049  0,047  Nicotinic receptor alpha7 subunit antagonist
0,042  0,041  Estrogen agonist
0,097  0,096  Microtubule formation inhibitor
0,067  0,067  Antineoplastic antibiotic

